Search





Search





US lobby group PhRMA CEO Steve Ubl to step down

ReutersApr 8, 2026 4:54 PM

April 8 (Reuters) - Steve Ubl, the chief executive of Pharmaceutical Research and Manufacturers of America, plans to step down at the end of the year, the U.S. pharmaceutical lobby group said on Wednesday.

Ubl communicated his decision to the board, which will begin a search for his successor. Ubl will remain in his role until a new CEO is appointed to ensure a smooth transition.

Ubl has been the CEO of Pharmaceutical Research and Manufacturers of America since September 2015.

Before joining PhRMA, Ubl served as president and CEO of AdvaMed, the medical device industry's top trade association.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Tradingkey

Recommended Articles

Iran Discloses All 10 Ceasefire Terms, Who Is the Winner Between US and Iran? What Are the Impacts on Global Assets?

TradingKey - Iran’s Supreme National Security Council issued a statement on the 8th disclosing the key contents of 10 ceasefire terms submitted to the United States via Pakistan. Iranian media subsequently released all 10 terms, though the reports were not entirely consistent.

Ceasefire Expectations Push Oil Prices Below $100, Intraday Drop Near $20, Where Do Oil Prices Go Next?

TradingKey - The core driver of this round of oil price declines is not a sudden weakening of supply and demand data, but rather a swift correction of the market's worst-case expectations for the Middle East situation.

Apple Shares Plunge 5% After Foldable iPhone Engineering Scare—Where is the Next 'iPhone Moment'?

TradingKey - During the April 7 US trading session, Apple (AAPL) shares fell more than 5% intraday, hitting a low of $245.7. A report from Nikkei indicated that Apple encountered setbacks during the engineering testing phase of its first foldable iPhone, which could potentially delay mass production

Anthropic Revenue Surpasses OpenAI for First Time, IPO as Early as October

TradingKey - April 7, 2026, Anthropic released two major updates: **Stellar Performance:** Annualized revenue surpassed $30 billion, exceeding OpenAI’s $25 billion, making it the world's highest-earning AI unicorn. **Computing Power Secured:** Reached new agreements with Broadcom and Google to sec

Meta Is About to Launch a Consumer-Facing AI Model, and OpenAI Is About to Have Its IPO, Making Now a Good Time to Buy Meta Stock

TradingKey - As of April 07, 2026, the stock price of Meta Platforms, Inc. (NASDAQ:META) is approximately $573. The second half of 2025 was a great period for this stock as it increased nearly 12%. However, in Q1 of 2026, Meta's stock dropped 13.5%, which was the largest decline since Q4 of 2022.

Tradingkey

KeyAI

